What is bttn?
bttn. operates as a medical supply procurement platform, integrating technology, web-based ordering, and big data insights. The company's mission is to democratize access to essential products for healthcare workers by dismantling exclusive and restrictive contracts. This strategic positioning aims to streamline the procurement process and enhance efficiency within the healthcare supply chain.
The company's focus on leveraging technology for procurement solutions places it at the intersection of health tech and supply chain innovation.
How much funding has bttn raised?
bttn has raised a total of $26.5M across 2 funding rounds:
Angel/Seed
$6.5M
Series A
$20M
Angel/Seed (2021): $6.5M with participation from Amol Deshpande and Fuse
Series A (2022): $20M led by Tiger Global Management and Fuse
Key Investors in bttn
Amol Deshpande
Amol Deshpande is an individual investor who participated in the seed funding round for bttn.
Fuse
Fuse is an early-stage venture capital firm that has provided backing to bttn. in its seed funding round.
Tiger Global Management
Tiger Global Management is a prominent investment firm known for its significant capital deployments in both public and private markets, participating in bttn.'s Series A funding.
What's next for bttn?
With the recent infusion of capital, bttn. is poised for accelerated expansion and further development of its procurement platform. The major strategic investment suggests a focus on scaling operations, enhancing technological capabilities, and potentially broadening its market reach. Future initiatives are likely to concentrate on solidifying its position as a key player in the medical supply procurement landscape, driven by data-driven insights and a commitment to democratizing product access for essential workers.
The company's ability to attract significant backing highlights the perceived value and potential of its business model in addressing critical needs within the healthcare industry.
